IL2 and type 1 diabetes mellitus: It has already been reported that Tregs from patients with diabetes exhibit deficient IL-2 production and/or signaling, and if the IL-2 pathway is blocked, the frequency of Tregs decreases, and the number of individuals affected by T1D increases [39].